Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Y Shapira

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Cancers|August 27, 2021
The Impact of Induction Regimes on Immune Responses in Patients with Multiple MyelomaMichael A Firer, Michael Y Shapira, Galia Luboshits
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2018
Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in LymphomaSigal Grisariu, Michael Y Shapira, Reuven Or, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2003
Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host diseaseSharon Elad, Reuven Or, Igor Resnick, et al.
Annals of Medicine|March 18, 2011
The role of natural killer cells in hematopoietic stem cell transplantationPanagiotis D Tsirigotis, Igor B Resnick, Michael Y Shapira
Expert Opinion on Pharmacotherapy|January 14, 2017
Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonideYehuda Zadik, Sharon Elad, Anat Shapira, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|March 11, 2003
Budesonide: a novel treatment for oral chronic graft versus host diseaseSharon Elad, Reuven Or, Adi A Garfunkel, et al.
American Journal of Hematology|April 18, 2003
Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donorsMichael Y Shapira, Pavel Kaspler, Simcha Samuel, et al.
Expert Opinion on Biological Therapy|April 14, 2006
Biological response modifiers as adjuncts to stem cell transplantationMichael Y Shapira, Igor B Resnick, Panagiotis D Tsirigotis, et al.
Echocardiography (Mount Kisco, N.Y.)|February 15, 2001
Esophageal Perforation After Transesophageal EchocardiogramMichael Y. Shapira, Boaz Hirshberg, Ronit Agid, et al.
Oral Oncology|February 20, 2007
A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantationSharon Elad, Todd Thierer, Menachem Bitan, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Cancers|August 27, 2021
The Impact of Induction Regimes on Immune Responses in Patients with Multiple MyelomaMichael A Firer, Michael Y Shapira, Galia Luboshits
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2018
Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in LymphomaSigal Grisariu, Michael Y Shapira, Reuven Or, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2003
Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host diseaseSharon Elad, Reuven Or, Igor Resnick, et al.
Annals of Medicine|March 18, 2011
The role of natural killer cells in hematopoietic stem cell transplantationPanagiotis D Tsirigotis, Igor B Resnick, Michael Y Shapira
Expert Opinion on Pharmacotherapy|January 14, 2017
Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonideYehuda Zadik, Sharon Elad, Anat Shapira, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|March 11, 2003
Budesonide: a novel treatment for oral chronic graft versus host diseaseSharon Elad, Reuven Or, Adi A Garfunkel, et al.
American Journal of Hematology|April 18, 2003
Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donorsMichael Y Shapira, Pavel Kaspler, Simcha Samuel, et al.
Expert Opinion on Biological Therapy|April 14, 2006
Biological response modifiers as adjuncts to stem cell transplantationMichael Y Shapira, Igor B Resnick, Panagiotis D Tsirigotis, et al.
Echocardiography (Mount Kisco, N.Y.)|February 15, 2001
Esophageal Perforation After Transesophageal EchocardiogramMichael Y. Shapira, Boaz Hirshberg, Ronit Agid, et al.
Oral Oncology|February 20, 2007
A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantationSharon Elad, Todd Thierer, Menachem Bitan, et al.
Pageof 7